<DOC>
	<DOCNO>NCT00648375</DOCNO>
	<brief_summary>This study evaluate effectiveness propranolol reduce symptom distress people post-traumatic stress disorder .</brief_summary>
	<brief_title>Effectiveness Propranolol For Treating People With Post-Traumatic Stress Disorder</brief_title>
	<detailed_description>Post-traumatic stress disorder ( PTSD ) common disable condition , 10 % people experience PTSD point life . The diagnosis PTSD require certain criterion : exposure severe psychological trauma persistent presence three symptom cluster include re-experiencing traumatic event , physiologic hyperarousal , emotional numbing pair avoidance stimulus associate event . Stimuli cue associate trauma , feature assailant accident site , cause person re-experience traumatic memory associate feeling helplessness fear . When re-experiencing traumatic memory , people PTSD usually undergo heighten stress-related hormonal response solidify new stimulate association traumatic memory . Treatment propranolol , blood pressure-lowering drug reduces stress-related hormonal response , may effective mean prevent formation traumatic memory improve PTSD symptom . This study evaluate effectiveness propranolol reduce symptom distress associate traumatic memory people PTSD . Participation study last 14 week . All potential participant undergo 4-hour initial visit begin medical psychiatric history review , psychiatric interview , symptom questionnaire . Participants assign randomly take test dose either propranolol placebo . Upon completion test dose , participant begin 14 week treatment assign test dose medication . Participants ask take study medication time traumatic memory associate hyperarousal symptom , two time day . Using cognitive behavioral therapy based-workbook , participant track symptom daily use cognitive technique relieve symptom . Participants attend study visit every 2 week 14 week treatment . During visit , participant describe side effect experience , complete interview questionnaire PTSD symptom severity , review study official daily workbook entry , pick medication . Study participation end upon completion Week 14 study visit . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00391430</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>DSMIV diagnosis PTSD meet five six diagnostic criterion PTSD ( event , hyperarousal , reexperiencing , duration , distress/impaired function symptom criterion ) , avoidance/numbing symptom criterion Past current asthma Diabetes heart disease Currently pregnant breastfeed Concurrent use daily benzodiazepine ; daily use antidepressant medication allow dose stable 3 month study entry Exposure therapy additional cognitive therapy course study ( supportive psychotherapy allow ongoing least 3 month study entry ) Substance abuse Current use beta blocker , amiodarone , chlorpromazine , cimetidine , clonidine , digoxin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Propanolol</keyword>
	<keyword>Beta Blockers</keyword>
	<keyword>Reconsolidation</keyword>
	<keyword>Cognitive Therapy</keyword>
	<keyword>PTSD</keyword>
</DOC>